Article

Utility of gene tumor expression of<i>VEGF, FOXM1*3</i>and<i>CD-133</i>on diagnosis and prognosis of brain gliomas

2020-08-17

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objective</h4> This paper seeks to quantify the normalized expression of transcripts FOXM1*3, VEGF, CD133 , and MGMT and their relation with the histopathological and molecular diagnosis and with the probability of estimating tumor progression-free survival of gliomas. <h4>Methods</h4> A cohort of patients was made up of patients aged over 18 years with a histological and molecular diagnosis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6693f73b-ddc0-5144-9791-44dc6e2251dd
DOI: 10.1101/2020.08.15.20175166

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Utility of gene tumor expression of<i>VEGF, FOXM1*3</i>and<i>CD-133</i>on diagnosis and prognosis of brain gliomasDOI 10.1101/2020.08.15.20175166Read

A model of molecular characteristics to classify patients with WHO Grade III gliomasSemantic proximity Read

RRN3P2, RPL7AP64, ACTR3C, & RPL7AP30 as Novel Prognostic Biomarkers for Glioblastoma (GBM): A Bioinformatics-Based AnalysisSemantic proximity Read

Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review.Semantic proximity Read

Prognostic Value of a Nomogram Model Based on Tumor Immune Markers and Clinical Factors for Adult Primary GliomasSemantic proximity Read

Unravelling the role of Exosomes as early non-invasive predictors of disease state in GlioblastomaSemantic proximity Read

Tumor Mutation Burden and Tumor Microenvironment as Biomarkers of Glioma Treatment Outcome and Prognosis- A Systematic Review and Meta-Analysis ProtocolSemantic proximity Read

RRN3P2, RPL7AP64, ACTR3C, & RPL7AP30 as Novel Prognostic Biomarkers for Glioblastoma (GBM): A Bioinformatics-Based AnalysisSemantic proximity Read

miR-200 family as new potential prognostic factor of overall survival of patients with WHO G2 and WHO G3 brain gliomasSemantic proximity Read

Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.Semantic proximity Read

The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study.Semantic proximity Read

Promising Prognosis Marker Candidates on the Status of Epithelial–Mesenchymal Transition and Glioma Stem Cells in GlioblastomaSemantic proximity Read

A prognostic model of newly diagnosed glioblastoma based on clinical characteristicsSemantic proximity Read